Canada markets closed

Hansoh Pharmaceutical Group Company Limited (3692.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
16.060+0.060 (+0.37%)
At close: 04:08PM HKT
Full screen
Previous Close16.000
Open16.300
Bid16.060 x N/A
Ask16.080 x N/A
Day's Range15.920 - 16.700
52 Week Range9.410 - 18.760
Volume6,717,433
Avg. Volume5,617,219
Market Cap95.238B
Beta (5Y Monthly)0.52
PE Ratio (TTM)28.18
EPS (TTM)0.570
Earnings DateAug 29, 2024 - Sept 02, 2024
Forward Dividend & Yield0.21 (1.33%)
Ex-Dividend DateJun 19, 2024
1y Target Est19.20
  • GlobeNewswire

    SCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China

    JERSEY CITY, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China’s National Medical Products Administration (NMPA) has accepted for review a New Drug Application (NDA) for oral ibrexafungerp tablets for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC) in the Chinese mainland.